1887

Abstract

Human adenovirus F41 causes acute gastroenteritis in children, and has recently been associated with an apparent increase in paediatric hepatitis of unknown aetiology in the UK, with further cases reported in multiple countries. Relatively little is known about the genetic diversity of adenovirus F41 in UK children; and it is unclear what, if any, impact the COVID-19 pandemic has had on viral diversity in the UK. Methods that allow F41 to be sequenced from clinical samples without the need for viral culture are required to provide the genomic data to address these questions. Therefore, we evaluated an overlapping-amplicon method of sequencing adenovirus genomes from clinical samples using Oxford Nanopore technology. We applied this method to a small sample of adenovirus-species-F-positive extracts collected as part of standard care in the East of England region in January–May 2022. This method produced genomes with >75 % coverage in 13/22 samples and >50 % coverage in 19/22 samples. We identified two F41 lineages present in paediatric patients in the East of England in 2022. Where F41 genomes from paediatric hepatitis cases were available (=2), these genomes fell within the diversity of F41 from the UK and continental Europe sequenced before and after the 2020–2021 phase of the COVID-19 pandemic. Our analyses suggest that overlapping amplicon sequencing is an appropriate method for generating F41 genomic data from high-virus-load clinical samples, and currently circulating F41 viral lineages were present in the UK and Europe before the COVID-19 pandemic.

Funding
This study was supported by the:
  • Wellcome Trust (Award 206298/B/17/Z)
    • Principle Award Recipient: GannaKovalenko
  • National Institute on Health Research
    • Principle Award Recipient: JordanP Skittrall
  • Wellcome Trust (Award 215515/Z/19/Z)
    • Principle Award Recipient: StephenBaker
  • This is an open-access article distributed under the terms of the Creative Commons Attribution License. This article was made open access via a Publish and Read agreement between the Microbiology Society and the corresponding author’s institution.
Loading

Article metrics loading...

/content/journal/mgen/10.1099/mgen.0.000920
2023-01-06
2024-03-28
Loading full text...

Full text loading...

/deliver/fulltext/mgen/9/1/mgen000920.html?itemId=/content/journal/mgen/10.1099/mgen.0.000920&mimeType=html&fmt=ahah

References

  1. Rowe WP, Huebner RJ, Gilmore LK, Parrott RH, Ward TG. Isolation of a cytopathogenic agent from human adenoids undergoing spontaneous degeneration in tissue culture. Proc Soc Exp Biol Med 1953; 84:570–573 [View Article]
    [Google Scholar]
  2. Hilleman MR, Werner JH. Recovery of new agent from patients with acute respiratory illness. Proc Soc Exp Biol Med 1954; 85:183–188 [View Article]
    [Google Scholar]
  3. Lion T. Adenovirus infections in immunocompetent and immunocompromised patients. Clin Microbiol Rev 2014; 27:441–462 [View Article] [PubMed]
    [Google Scholar]
  4. de Jong JC, Wigand R, Kidd AH, Wadell G, Kapsenberg JG et al. Candidate adenoviruses 40 and 41: fastidious adenoviruses from human infant stool. J Med Virol 1983; 11:215–231 [View Article] [PubMed]
    [Google Scholar]
  5. Liu J, Platts-Mills JA, Juma J, Kabir F, Nkeze J et al. Use of quantitative molecular diagnostic methods to identify causes of diarrhoea in children: a reanalysis of the GEMS case-control study. Lancet 2016; 388:1291–1301 [View Article] [PubMed]
    [Google Scholar]
  6. Lee B, Damon CF, Platts-Mills JA. Pediatric acute gastroenteritis associated with adenovirus 40/41 in low-income and middle-income countries. Curr Opin Infect Dis 2020; 33:398–403 [View Article] [PubMed]
    [Google Scholar]
  7. Lefeuvre C, Salmona M, Feghoul L, Ranger N, Mercier-Delarue S et al. Deciphering an adenovirus F41 outbreak in pediatric hematopoietic stem cell transplant recipients by whole-genome sequencing. J Clin Microbiol 2021; 59:e03148-20 [View Article]
    [Google Scholar]
  8. van der Avoort HG, Wermenbol AG, Zomerdijk TP, Kleijne JA, van Asten JA et al. Characterization of fastidious adenovirus types 40 and 41 by DNA restriction enzyme analysis and by neutralizing monoclonal antibodies. Virus Res 1989; 12:139–157 [View Article] [PubMed]
    [Google Scholar]
  9. Lemiale F, Haddada H, Nabel GJ, Brough DE, King CR et al. Novel adenovirus vaccine vectors based on the enteric-tropic serotype 41. Vaccine 2007; 25:2074–2084 [View Article] [PubMed]
    [Google Scholar]
  10. Davison AJJ, Telford E, Watson MSS, McBride K, Mautner V. The DNA sequence of adenovirus type 40. J Mol Biol 1993; 234:1308–1316 [View Article] [PubMed]
    [Google Scholar]
  11. UKHSA Investigation into Acute Hepatitis of Unknown Aetiology in Children in England, Technical Briefing London: UK Health Security Agency; 2022
    [Google Scholar]
  12. UKHSA Investigation into Acute Hepatitis of Unknown Aetiology in Children in England, Technical Briefing 2 London: UK Health Security Agency; 2022
    [Google Scholar]
  13. Kelgeri C, Couper M, Gupte GL, Brant A, Patel M et al. Clinical spectrum of children with acute hepatitis of unknown cause. N Engl J Med 2022; 387:611–619 [View Article]
    [Google Scholar]
  14. Marsh K, Tayler R, Pollock L, Roy K, Lakha F et al. Investigation into cases of hepatitis of unknown aetiology among young children, Scotland, 1 January 2022 to 12 April 2022. Euro Surveill 2022; 27:2200318 [View Article]
    [Google Scholar]
  15. van Beek J, Fraaij PL, Giaquinto C, Shingadia D, Horby P et al. Case numbers of acute hepatitis of unknown aetiology among children in 24 countries up to 18 April 2022 compared to the previous 5 years. Euro Surveill 2022; 27:2200370 [View Article]
    [Google Scholar]
  16. Kambhampati AK, Burke RM, Dietz S, Sheppard M, Almendares O et al. Trends in acute hepatitis of unspecified etiology and adenovirus stool testing results in children – United States, 2017–2022. MMWR Morb Mortal Wkly Rep 2022; 71:797–802 [View Article]
    [Google Scholar]
  17. WHO Multi-Country – Acute, Severe Hepatitis of Unknown Origin in Children ( https://www.who.int/emergencies/disease-outbreak-news/item/2022-DON376) Geneva: World Health Organization; 2022
    [Google Scholar]
  18. WHO Severe Acute Hepatitis of Unknown Aetiology in Children – Multi-Country ( https://www.who.int/emergencies/disease-outbreak-news/item/2022-DON394) Geneva: World Health Organization; 2022
    [Google Scholar]
  19. UKHSA Hepatitis (Liver Inflammation) Cases in Children – Latest Updates ( https://www.gov.uk/government/news/hepatitis-liver-inflammation-cases-in-children-latest-updates) London: UK Health Security Agency; 2022
    [Google Scholar]
  20. UKHSA Investigation into Acute Hepatitis of Unknown Aetiology in Children in England: Technical Briefing 3 London: UK Health Security Agency; 2022
    [Google Scholar]
  21. UKHSA Investigation into Acute Hepatitis of Unknown Aetiology in Children in England: Case Update London: UK Health Security Agency; 2022
    [Google Scholar]
  22. Houldcroft CJ, Roy S, Morfopoulou S, Margetts BK, Depledge DP et al. Use of whole-genome sequencing of adenovirus in immunocompromised pediatric patients to identify nosocomial transmission and mixed-genotype infection. J Infect Dis 2018; 218:1261–1271 [View Article]
    [Google Scholar]
  23. Myers CE, Houldcroft CJ, Roy S, Margetts BK, Best T et al. Using whole genome sequences to investigate adenovirus outbreaks in a hematopoietic stem cell transplant unit. Front Microbiol 2021; 12:2020 [View Article]
    [Google Scholar]
  24. Götting J, Cordes AK, Steinbrück L, Heim A. Molecular phylogeny of human adenovirus type 41 lineages. bioRxiv 2022493978 [View Article]
    [Google Scholar]
  25. Quick J, Loman NJ, Duraffour S, Simpson JT, Severi E et al. Real-time, portable genome sequencing for Ebola surveillance. Nature 2016; 530:228–232 [View Article] [PubMed]
    [Google Scholar]
  26. Quick J, Grubaugh ND, Pullan ST, Claro IM, Smith AD et al. Multiplex PCR method for MinION and Illumina sequencing of Zika and other virus genomes directly from clinical samples. Nat Protoc 2017; 12:1261–1276 [View Article] [PubMed]
    [Google Scholar]
  27. Resende PC, Motta FC, Roy S, Appolinario L, Fabri A. SARS-CoV-2 genomes recovered by long amplicon tiling multiplex approach using nanopore sequencing and applicable to other sequencing platforms. bioRxiv 2020069039 [View Article]
    [Google Scholar]
  28. Meredith LW, Hamilton WL, Warne B, Houldcroft CJ, Hosmillo M et al. Rapid implementation of SARS-CoV-2 sequencing to investigate cases of health-care associated COVID-19: a prospective genomic surveillance study. Lancet Infect Dis 2020; 20:1263–1272 [View Article]
    [Google Scholar]
  29. Clark TW, Medina M, Batham S, Curran MD, Parmar S et al. Adults hospitalised with acute respiratory illness rarely have detectable bacteria in the absence of COPD or pneumonia; viral infection predominates in a large prospective UK sample. J Infect 2014; 69:507–515 [View Article] [PubMed]
    [Google Scholar]
  30. Tiemessen CT, Nel MJ. Detection and typing of subgroup F adenoviruses using the polymerase chain reaction. J Virol Methods 1996; 59:73–82 [View Article] [PubMed]
    [Google Scholar]
  31. Tahmasebi R, Luchs A, Tardy K, Hefford PM, Tinker RJ et al. Viral gastroenteritis in Tocantins, Brazil: characterizing the diversity of human adenovirus F through next-generation sequencing and bioinformatics. J Gen Virol 2020; 101:1280–1288 [View Article]
    [Google Scholar]
  32. Katoh K, Rozewicki J, Yamada KD. MAFFT online service: multiple sequence alignment, interactive sequence choice and visualization. Brief Bioinform 2019; 20:1160–1166 [View Article]
    [Google Scholar]
  33. Götting J, Baier C, Panagiota V, Maecker-Kolhoff B, Dhingra A et al. High genetic stability of co-circulating human adenovirus type 31 lineages over 59 years. Virus Evolution 2022; 8:veac067 [View Article]
    [Google Scholar]
  34. Tamura K, Stecher G, Kumar S. MEGA11: Molecular Evolutionary Genetics Analysis version 11. Mol Biol Evol 2021; 38:3022–3027 [View Article]
    [Google Scholar]
  35. Hoang DT, Chernomor O, von Haeseler A, Minh BQ, Vinh LS. UFBoot2: improving the ultrafast bootstrap approximation. Mol Biol Evol 2018; 35:518–522 [View Article]
    [Google Scholar]
  36. Nguyen L-T, Schmidt HA, von Haeseler A, Minh BQ. IQ-TREE: a fast and effective stochastic algorithm for estimating maximum-likelihood phylogenies. Mol Biol Evol 2015; 32:268–274 [View Article]
    [Google Scholar]
  37. Letunic I, Bork P. Interactive Tree Of Life (iTOL) v5: an online tool for phylogenetic tree display and annotation. Nucleic Acids Res 2021; 49:W293–W296 [View Article]
    [Google Scholar]
  38. Samson S, Lord É, Makarenkov V. SimPlot++: a Python application for representing sequence similarity and detecting recombination. Bioinformatics 2022; 38:3118–3120 [View Article] [PubMed]
    [Google Scholar]
  39. Argimón S, Abudahab K, Goater RJE, Fedosejev A, Bhai J et al. Microreact: visualizing and sharing data for genomic epidemiology and phylogeography. Microb Genom 2016; 2:e000093 [View Article]
    [Google Scholar]
  40. Tyson JR, James P, Stoddart D, Sparks N, Wickenhagen A et al. Improvements to the ARTIC multiplex PCR method for SARS-CoV-2 genome sequencing using nanopore. bioRxiv 2020283077 [View Article]
    [Google Scholar]
  41. Kajon AE, Hang J, Hawksworth A, Metzgar D, Hage E et al. Molecular epidemiology of adenovirus type 21 respiratory strains isolated from US military trainees (1996–2014). J Infect Dis 2015; 212:871–880 [View Article]
    [Google Scholar]
  42. Dhingra A, Hage E, Ganzenmueller T, Böttcher S, Hofmann J et al. Molecular evolution of human adenovirus (HAdV) species C. Sci Rep 2019; 9:1039 [View Article]
    [Google Scholar]
  43. Sammons JS, Graf EH, Townsend S, Hoegg CL, Smathers SA et al. Outbreak of adenovirus in a neonatal intensive care unit: critical importance of equipment cleaning during inpatient ophthalmologic examinations. Ophthalmology 2019; 126:137–143 [View Article]
    [Google Scholar]
  44. Oude Munnink BB, Kik M, de Bruijn ND, Kohl R, van der Linden A et al. Towards high quality real-time whole genome sequencing during outbreaks using Usutu virus as example. Infect Genet Evol 2019; 73:49–54 [View Article] [PubMed]
    [Google Scholar]
  45. Park SY, Faraci G, Ward PM, Emerson JF, Lee HY. High-precision and cost-efficient sequencing for real-time COVID-19 surveillance. Sci Rep 2021; 11:13669 [View Article]
    [Google Scholar]
  46. Riaz N, Leung P, Barton K, Smith MA, Carswell S et al. Adaptation of Oxford Nanopore technology for hepatitis C whole genome sequencing and identification of within-host viral variants. BMC Genomics 2021; 22:148 [View Article] [PubMed]
    [Google Scholar]
  47. Bull RA, Eltahla AA, Rodrigo C, Koekkoek SM, Walker M et al. A method for near full-length amplification and sequencing for six hepatitis C virus genotypes. BMC Genomics 2016; 17:247 [View Article] [PubMed]
    [Google Scholar]
  48. Davis JJ, Long SW, Christensen PA, Olsen RJ, Olson R et al. Analysis of the ARTIC version 3 and version 4 SARS-CoV-2 primers and their impact on the detection of the G142D amino acid substitution in the spike protein. Microbiol Spectr 2021; 9:e0180321 [View Article]
    [Google Scholar]
  49. Nasheri N, Petronella N, Ronholm J, Bidawid S, Corneau N. Characterization of the genomic diversity of norovirus in linked patients using a metagenomic deep sequencing approach. Front Microbiol 2017; 8:73 [View Article]
    [Google Scholar]
  50. UKHSA Investigation into Monkeypox Outbreak in England: Technical Briefing 1 ( https://www.gov.uk/government/publications/monkeypox-outbreak-technical-briefings/investigation-into-monkeypox-outbreak-in-england-technical-briefing-1) London: UK Health Security Agency; 2022
    [Google Scholar]
  51. Al-Soud WA, Jönsson LJ, Râdström P. Identification and characterization of immunoglobulin G in blood as a major inhibitor of diagnostic PCR. J Clin Microbiol 2000; 38:345–350 [View Article] [PubMed]
    [Google Scholar]
  52. Schrader C, Schielke A, Ellerbroek L, Johne R. PCR inhibitors – occurrence, properties and removal. J Appl Microbiol 2012; 113:1014–1026 [View Article]
    [Google Scholar]
  53. Borrows CL, Turner PC. Seasonal screening for viral gastroenteritis in young children and elderly hospitalized patients: is it worthwhile?. J Hosp Infect 2014; 87:98–102 [View Article] [PubMed]
    [Google Scholar]
  54. Gutierrez Sanchez LH, Shiau H, Baker JM, Saaybi S, Buchfellner M et al. A case series of children with acute hepatitis and human adenovirus infection. N Engl J Med 2022; 387:620–630 [View Article]
    [Google Scholar]
  55. Torres S, Chodosh J, Seto D, Jones MS. The revolution in viral genomics as exemplified by the bioinformatic analysis of human adenoviruses. Viruses 2010; 2:1367–1381 [View Article] [PubMed]
    [Google Scholar]
  56. Oliveira ERA, Bouvier M. Immune evasion by adenoviruses: a window into host-virus adaptation. FEBS Lett 2019; 593:3496–3503 [View Article] [PubMed]
    [Google Scholar]
  57. Oliveira ERA, Li L, Bouvier M. Intracellular sequestration of the NKG2D ligand MIC B by species F adenovirus. Viruses 2021; 13:1289 [View Article]
    [Google Scholar]
  58. Bridge E, Ketner G. Redundant control of adenovirus late gene expression by early region 4. J Virol 1989; 63:631–638 [View Article] [PubMed]
    [Google Scholar]
  59. Carapito R, Bahram S. Genetics, genomics, and evolutionary biology of NKG2D ligands. Immunol Rev 2015; 267:88–116 [View Article] [PubMed]
    [Google Scholar]
  60. PHE UK Standards for Microbiology Investigations: Evaluation, Validation and Verifications of Diagnostic Tests, Report Q1 London: Public Health England; 2017
    [Google Scholar]
  61. HM Government Human Tissue Act 2004 ( https://www.legislation.gov.uk/ukpga/2004/30/contents) London: HM Government; 2004
    [Google Scholar]
  62. Ho A, Orton R, Tayler R, Asamaphan P, Tong L et al. Adeno-associated virus 2 infection in children with non-A-E hepatitis. medRxiv 2022 [View Article]
    [Google Scholar]
  63. Neto Z, Martinez PA, Hill SC, Jandondo D, Thézé J et al. Molecular and genomic investigation of an urban outbreak of dengue virus serotype 2 in Angola, 2017–2019. PLoS Negl Trop Dis 2022; 16:e0010255 [View Article]
    [Google Scholar]
  64. England PH. Public Health England UK Standards for Microbiology Investigations: Q1. Evaluation, validation and verifications of diagnostic tests UK Standards for Microbiology Investigations Report No Q1; 2017
  65. Human Tissue Act 2004. n.d https://www.legislation.gov.uk/ukpga/2004/30/contents accessed 27 June 2022
http://instance.metastore.ingenta.com/content/journal/mgen/10.1099/mgen.0.000920
Loading
/content/journal/mgen/10.1099/mgen.0.000920
Loading

Data & Media loading...

Supplements

Supplementary material 1

PDF

Supplementary material 2

EXCEL
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error